Boost For BMRN Pipeline
Recently, BioMarin Pharmaceutical Inc.’s (NASDAQ:BMRN) pipeline received a boost with the UK regulatory body, the Medicines and Healthcare Products Regulatory Agency (MHRA) completing the scrutiny of the clinical trial application (CTA) for BMN 673 for treating patients suffering from genetically-defined cancers. The agency subsequently issued a notice of acceptance for the candidate. The company intends [...]
Mad Money / Jim Cramer Daily Recap 10/11/10
On Monday Cramer said that Chesapeake Energy (CHK) should be worth $73 a share, over double its sub $24 share price at today’s close. Bullish Alcoa (AA) (Lightning Round) Alexion Pharmaceuticals (ALXN) (featured) BioMarin (BMRN) (featured) Boeing (BA) (discussed) Chesapeake Energy (CHK) (featured) Deere & Co (DE) (discussed) JC Penney (JCP) (discussed) Masco (MAS) (Lightning Round) Nucor (NUE) (discussed) Stanley Works (SWK) (Lightning Round) Verizon (VZ) (Lightning [...]
BioMarin to buy ZyStor for up to $115M
BioMarin Pharmaceutical Inc. will buy ZyStor Therapeutics Inc. and a possible treatment for a rare degenerative muscle disease in a deal that could be worth up to $115 million. (BMRN)
Stocks To Watch Next Week
What Google thinks of Biomarin Pharmaceutical Inc.
Seasonality Analysis of BMRN
Historical data for BMRN
Biomarin Pharmaceutical Inc. at ValueWiki
Experimental Head and Shoulders chart patterns identified today
Experimental Inverted Head and Shoulders chart patterns identified today
Stocks with Positive Correlation to BMRN
Stocks with Negative Correlation to BMRN
Previous symbol is BMRMF
Next symbol is BMRRX